Log on / register
Feedback | Support | My details

Comments

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

Florian Then Bergh* email, Tania Kümpfel* email, Erina Schumann email, Ulrike Held email, Michaela Schwan email, Mirjana Blazevic email, Axel Wismüller email, Florian Holsboer email, Alexander Yassouridis email, Manfred Uhr email, Frank Weber email, Martin Daumer email, Claudia Trenkwalder email and Dorothee P Auer email

BMC Neurology 2006, 6:19doi:10.1186/1471-2377-6-19

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated